Feagins LA, Kane SV Sexual and reproductive issues for men with inflammatory bowel disease. Am J Gastroenterol. 2009 Mar;104(3):768-73. doi: 10.1038/ajg.2008.90. Epub 2009 Feb 17. Review.
Ireland A, Jewell DP Sulfasalazine-induced impotence: a beneficial resolution with olsalazine? J Clin Gastroenterol. 1989 Dec;11(6):711.
Riba N, Moreno F, Costa J, Olive A [Appearance of impotence in relation to the use of methotrexate]. Med Clin (Barc). 1996 Apr 13;106(14):558. Spanish.
Sussman A, Leonard JM Psoriasis, methotrexate, and oligospermia. Arch Dermatol. 1980 Feb;116(2):215-7.
Thomas E, Koumouvi K, Blotman F Impotence in a patient with rheumatoid arthritis treated with methotrexate. J Rheumatol. 2000 Jul;27(7):1821-2.
Timmer A, Bauer A, Dignass A, Rogler G Sexual function in persons with inflammatory bowel disease: a survey with matched controls. Clin Gastroenterol Hepatol. 2007 Jan;5(1):87-94.
Timmer A, Bauer A, Kemptner D, Fürst A, Rogler G Determinants of male sexual function in inflammatory bowel disease: a survey-based cross-sectional analysis in 280 men. Inflamm Bowel Dis. 2007 Oct;13(10):1236-43.
Timmer A, Kemptner D, Bauer A, Takses A, Ott C, Fürst A Determinants of female sexual function in inflammatory bowel disease: a survey based cross-sectional analysis. BMC Gastroenterol. 2008 Oct 3;8:45. doi: 10.1186/1471-230X-8-45.
Investigation of Sexual Function in Crohn's Disease Patients With Perianal Fistulas
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
